Disease Mortality In China Research Articles

Trends in parkinson’s disease mortality in China from 2004 to 2021: a joinpoint analysis

BackgroundThis study aimed to analyze the trends of Parkinson’s disease (PD) mortality rates among Chinese residents from 2004 to 2021, provide evidence for the formulation of PD prevention and control strategies to improve the quality of life among PD residents.MethodsDemographic and sociological data such as gender, urban or rural residency and age were obtained from the National Cause of Death Surveillance Dataset from 2004 to 2021. We then analyzed the trends of PD mortality rates by Joinpoint regression.ResultsThe PD mortality and standardized mortality rates in China showed an overall increasing trend during 2004–2021 (average annual percentage change [AAPC] = 7.14%, AAPCASMR=3.21%, P < 0.001). The mortality and standardized mortality rate in male (AAPC = 7.65%, AAPCASMR=3.18%, P < 0.001) were higher than that of female (AAPC = 7.03%, AAPCASMR=3.09%, P < 0.001). The PD standardized mortality rates of urban (AAPC = 5.13%, AAPCASMR=1.76%, P < 0.001) and rural (AAPC = 8.40%, AAPCASMR=4.29%, P < 0.001) residents both increased gradually. In the age analysis, the mortality rate increased with age. And the mortality rates of those aged > 85 years was the highest. Considering gender, female aged > 85 years had the fastest mortality trend (annual percentage change [APC] = 5.69%, P < 0.001). Considering urban/rural, rural aged 80–84 years had the fastest mortality trend (APC = 6.68%, P < 0.001).ConclusionsThe mortality rate of PD among Chinese residents increased from 2004 to 2021. Male sex, urban residence and age > 85 years were risk factors for PD-related death and should be the primary focus for PD prevention.

Transitions in Chronic Disease Mortality in China: Evidence and Implications.

Transitions in Chronic Disease Mortality in China: Evidence and Implications.

Cardiovascular Disease Mortality Attributable to Low Whole-Grain Intake in CHINA: An Age-Period-Cohort and Joinpoint Analysis.

Cardiovascular disease (CVD) is the leading cause of death worldwide. Low whole-grain intake is found to be one of the most important risk factors for cardiovascular disease development and progression. In this study, we focused on exploring the long-term trends of low whole-grain intake attributed to cardiovascular disease mortality in China during 1990–2019 and relative gender differences. Study data were obtained from the Global Burden of Disease (GBD) 2019 study. We used the age-period-cohort model to estimate the adjusted effect of age, period, and cohorts. Annual and average annual percentage changes were estimated by joinpoint regression analysis. We observed an increasing trend with a net drift of 1.208% for males and 0.483% for males per year. The longitudinal age curve suggested that the attributed rate increased for both genders. Period and cohort effects all suggested that the risk for males showed an increased trend that was higher than that of females. Our findings suggest that males and senior-aged people were at a higher risk of cardiovascular disease mortality attributed to low whole-grain intake. Effective strategies are needed to enhance people’s health consciousness, and increasing whole-grain intake may achieve a better preventive effect for cardiovascular disease.

Influences of using different spatial weight matrices in analyzing spatial autocorrelation of cardiovascular diseases mortality in China

Objective: To explore the potential influences and applicability of different spatial weight matrices used in analyzing spatial autocorrelation of cardiovascular disease (CVD) mortality in China. Methods: Using data from the National Cause-of-death Reporting System, we used adjacency-based Rook and Queen contiguity and distance-based K nearest neighbors/distance threshold. We then conducted global and local spatial autocorrelation analysis of CVD mortality at the county level in China, 2018. Results: All four categories and 26 types of spatial weight matrices had detected significant global and local spatial autocorrelation of CVD mortality in China. Global Moran's I statistics reached its peak when using first-order Rook (0.406), first-order Queen (0.406), K nearest neighbors including five spatial units (0.409), and distance threshold with 100 kilometers (0.358). Meanwhile, apparent local spatial autocorrelation was found in CVD mortality. Substantial disparities were observed when detecting "High-High clusters", "Low-Low clusters", "High-Low clusters" and "Low-High clusters" of CVD mortality spatial distribution by using different weight matrices. Conclusions: Using different spatial weight matrices in analyzing the spatial autocorrelation of CVD mortality, we could understand the spatial distribution characteristics of CVD mortality in-depth at the county level in China. In this way, adequate supports could also be provided on CVD premature death control and rational medical resource allocation regionally.

Level and trend of respiratory diseases mortality in China from 2002 to 2016

Objective: To analyze the level and trend of respiratory disease mortality in China from 2002 to 2016. Methods: The standardized mortality rates were calculated based on the China health statistics yearbook (2003-2012) and China statistical yearbook of health and family planning (2013-2017) data released by the statistical information center of National health Commission of the People's Republic of China. Joinpoint model was used to calculate the standardized mortality rates (SMR), Annual percentage change (APC) and the average annual percentage change (AAPC) for standardized mortality rates. Results: The SMR of respiratory diseases and chronic lower respiratory diseases were decreased significantly in 2002 to 2016 (AAPC=-3.6%, AAPC=-6.4%, P<0.001, respectively). The SMR of lung cancer showed a significant increase trend (AAPC=1.6%, P=0.001). There were no significant differences in the SMR of pneumonia and pneumonoconiosis (APCC=1.0%, P=0.242; APCC=-0.2%, P=0.905). Both urban and rural SMR of respiratory diseases were declining significantly (AAPC=-2.9%, P=0.001; AAPC=-4.2%, P<0.001). Both urban and rural SMR of lung cancer showed an increasing trend (AAPC=0.6%, P=0.022; AAPC=2.1%, P=0.003, respectively). The SMR of pneumonia in urban areas showed an upward trend (AAPC=2.7%, P=0.017). The SMR of respiratory disease of all age groups (<35 years old, 35-65 years old and ≥65 years old) showed a downward trend (AAPC=-3.8%, P=0.001; AAPC=-2.6%, P<0.001; AAPC=-3.9%, P<0.001). The SMR of pneumonia between 35 and 65 years old and SMR of lung cancer over 65 years old showed an increasing trend (AAPC=2.8%, P=0.001; AAPC=2.4%, P<0.001). The SMR of respiratory diseases among males and females showed a downtrend (AAPC=-3.1%, P<0.001; AAPC=-4.3%, P<0.001). However, the SMR of lung cancer in males and females increased significantly (AAPC=1.2%, P<0.001; AAPC=2.5%, P<0.001, respectively). There were no significant trends in the SMR of pneumonia and pneumoconiosis in males (AAPC=1.5%, P=0.096; AAPC=-1.6%, P=0.218). There was no obvious trend in the SMR of pneumonia in females (AAPC=-0.1%, P=0.872). Conclusions: The SMR of respiratory diseases in China generally shows a downward trend. The overall SMR and SMR of major respiratory diseases varies among different regions, genders and age groups.

Secular trends and rural-urban differences in endocrine and metabolic disease mortality in China: an age-period-cohort modeling of National Data

Annual mortality of endocrine and metabolic diseases (EMD) in a population reflects levels of economy-related lifestyles and medical care, both of which have changed substantially in China in the last hundred years. Linking these two factors with historical trends of EMD will enhance our understanding of the EMD epidemiology. Age-specific annual mortality rates of EMD from 1991 to 2016 were derived from the Health Statistics Yearbook of China and analyzed by rural and urban using age-period-cohort (APC) method. Intrinsic estimator was performed for parameter estimation. The data fit APC models well. After controlling the influence of age, the estimated period effect increased rapidly from 1991 to 2001 before it leveled off. The risk for urban area increased faster than for rural area before 2006. Contrarily, the estimated cohort effects across 100 years from 1911 to 2016 showed an overall declining trend. For urban area, the cohort effect declined progressively since the 1911–1915 birth cohort with small fluctuations, while the same effect for rural area increased slowly from the 1911–1915 cohort to the 1951–1956 cohort before it declined, intercepting twice with that of urban one at cohort 1941–45 and another at 1996–2000. Increases in EMD mortality in China since 1991 can be explained primarily by the period effect, reflecting unhealthy lifestyles adapted along with rapid economic growth. The 100-year declines in cohort effect and the rural-urban differences could be largely attributed to the overall progress and rural-urban inequity in medical and healthcare. Future public health planning and decision-making must emphasize these two factors.

Moderately cold temperature associates with high cardiovascular disease mortality in China

Ambient air temperature is a key index that affects human health, including mortality risks of cardiovascular disease (CVD). This study quantitatively investigated CVD mortality burden with respect to various segments across the climatic temperature range. Daily data on average temperature and CVD deaths in nine Chinese cities during 2010–2016 were collected for the study. The association between temperature and city-specific CVD mortality was investigated with a distributed lag nonlinear model across lag 0–21 days for cold temperature and lag 0–2 days for hot temperature, and then pooled the association results in a multivariate meta-analysis to derive the pooled estimates of temperature on CVD mortality at national level. Attributable fractions of CVD mortality to cold- and heat-related (i.e., at temperatures below and above the minimum mortality temperature [MMT]) were calculated. In addition, temperature was further separated at 1 °C intervals of ambient temperature and the attributable fractions of each range were calculated. The results showed that the MMT varied from the 71th to 79th percentiles of temperature in nine Chinese cities, centering at 76th at national level. In total, 16.88% of CVD mortality was attributable to nonoptimal temperature, ranging from 9.73% in Hefei to 24.48% in Nanjing. Cold temperature was responsible for most CVD death burden, with a fraction of 14.62%, compared with 2.26% CVD mortality for heat at overall level. The results of temperature stratification suggested that the highest CVD deaths due to temperature fall within moderate cold. Specifically, the highest attributable fractions were at 7 °C, 7 °C, 8 °C, 4 °C, 5 °C, 4 °C, 4 °C, 5 °C, and 6 °C for Harbin, Changchun, Shenyang, Beijing, Shijiazhuang, Nanjing, Hefei, Shanghai, and Chengdu, respectively. Furthermore, the highest CVD deaths due to temperature were near at the start and end time of heating for five northern cities (Harbin, Changchun, Shenyang, Beijing, and Shijiazhuang). Hence, moderately cold temperature plays a noticeable role in impact mortality. Although moderate cold had a slightly lower relative risk than extreme cold, it occurred on more days than did extreme cold. Finally, the cumulative total counts of CVD deaths caused by moderate cold were the largest. We should pay more attention to the adverse health effects of moderate cold in the future. Additionally, the government and heating departments should slow down the rate of increase (or decrease) temperature at the start (or end) time of heating during moderate time in northern China. The findings have important implications for health promotion and disease prevention strategies of adverse temperatures.

Spatiotemporal variations in cardiovascular disease mortality in China from 1991 to 2009

BackgroundIn China, the spatiotemporal variations in cardiovascular disease (CVD) mortality are seldom characterized to understand their epidemiological features. It would be helpful to evaluate the performance of CVD-related interventions for subsequent adjustments.MethodsThe 2010 Census data as well as the coronary heart disease (CHD) and stroke mortality data from the Disease Surveillance Points (DSPs) were used to calculate the age standardized death rates (ASDRs) of CVD in the DSP counties during 1991–1995, 1996–2000, 2004–2005, and 2006–2009. The ordinary kriging (OK) method was used to estimate the county-level death rates of CHD and stroke and achieved satisfactory results.ResultsThe goodness-of-fit between measured and estimated values of CVD mortality was significant at the 0.01 level (0.34 < R2 < 0.98). The counties with high CHD death rates (> 75 per 105) were located in the Northwest, North, and Northeast in 1991–2000 and then extended toward the North, Central, and South, yielding an inverted-triangle-shaped area in 2004–2009. The counties with a CHD death rate increase greater than 100% were concentrated in the Northeast and South. The Northeast-Southwest regions with a high stroke death rate gradient (> 150 per 105) narrowed in1991–2000, was followed by a slight expansion during 2004–2005, finally reducing in 2006–2009. The counties with a stroke mortality increase greater than 100% were scattered across the Northeast, Northwest, Central, and South.ConclusionThe epidemiological characteristics of both CHD and stroke mortality in China was spatiotemporally featured on the county level during 1991–2009.

Level and trend of cardiovascular disease mortality in China from 2002 to 2016

Objective: To investigate the level and trend of cardiovascular disease mortality in China from 2002 to 2016. Methods: Using data of China Health Statistics Yearbook (2003-2012) and China's Health and Family Planning Statistical Yearbook (2013-2017),we calculated the age-standardized mortality rates (ASMR) in China. Joinpoint regression model was employed to estimate the annual percent change (APC) and average annual percent change (AAPC) of cardiovascular disease ASMR. Results: (1)The ASMR of cardiovascular disease were 225.65/100 thousands, 242.74/100 thousands, 214.63/100 thousands, 240.97/100 thousands, 195.24/100 thousands, 201.50/100 thousands, 208.83/100 thousands, 248.44/100 thousands, 261.38/100 thousands, 231.98/100 thousands, 210.25/100 thousands, 237.80/100 thousands, 235.21/100 thousands, 237.58/100 thousands,and 237.25/100 thousands from 2002 to 2016, and there was no significant difference in ASMR of cardiovascular disease (AAPC=0.2%, P>0.05) . The ASMR of chronic rheumatic heart disease decreased significantly (AAPC=-4.5%,P<0.05). There were no significant differences in ASMR of cerebrovascular disease, hypertensive heart disease, and ischemic heart disease (AAPC=0, P>0.05; AAPC=2.0%, P>0.05; AAPC=4.3%, P>0.05, respectively). (2) There were no significant differences in ASMR of cardiovascular disease from 2002 to 2016 in city and country (AAPC=-0.7%, P>0.05; AAPC=0.8%, P>0.05, respectively). The ASMR of chronic rheumatic heart disease decreased significantly in city and rural area (AAPC=-4.4%, P<0.05; AAPC=-4.6%, P<0.05, respectively). (3) There were no significant differences in ASMR of cardiovascular disease from 2002 to 2016 in male and female (AAPC=-0.3%,P>0.05; AAPC=-0.2%,P>0.05,respectively). The ASMR of chronic rheumatic heart disease decreased significantly in female (AAPC=-4.2%, P<0.05). The ASMR of ischemic heart disease increased significantly in male and female (AAPC=4.7%,P<0.05; AAPC=5.2%,P<0.05,respectively). (4) The ASMR of cardiovascular disease showed a significant upward trend in residents aged 15 to 34 from 2002 to 2016 (AAPC=3.1, P<0.05). There were no significant differences in ASMR of cardiovascular disease in residents aged 35 to 64 and ≥65 (AAPC=-0.1%, P>0.05; AAPC=-0.2%, P>0.05, respectively). Conclusion: The ASMR of cardiovascular disease in China remains stable during 2002 to 2016, and the ASMR of cardiovascular disease shows upward trend among young people.

Time trend of cardiometabolic risk factors over a 10-year period in the office-working population in China

ObjectivesRecent dramatic increases in cardiovascular disease mortality in China can be mostly explained by adverse changes in hypertension, dyslipidaemia, diabetes and obesity, known as cardiometabolic risk factors. Our study aimed...

Ambient carbon monoxide and cardiovascular mortality: a nationwide time-series analysis in 272 cities in China

Evidence of the acute health effects of ambient carbon monoxide air pollution in developing countries is scarce and mixed. We aimed to evaluate short-term associations between carbon monoxide and daily cardiovascular disease mortality in China. We did a nationwide time-series analysis in 272 major cities in China from January, 2013, to December, 2015. We extracted daily cardiovascular disease mortality data from China's Disease Surveillance Points system. Data on daily carbon monoxide concentrations for each city were obtained from the National Urban Air Quality Real-time Publishing Platform. City-specific associations between carbon monoxide concentrations and daily mortality from cardiovascular disease, coronary heart disease, and stroke were estimated with over-dispersed generalised linear models. Bayesian hierarchical models were used to obtain national and regional average associations. Exposure-response association curves and potential effect modifiers were evaluated. Two-pollutant models were fit to evaluate the robustness of the effects of carbon monoxide on cardiovascular mortality. The average annual mean carbon monoxide concentration in these cities from 2013 to 2015 was 1·20 mg/m3, ranging from 0·43 mg/m3 to 2·45 mg/m3. For a 1 mg/m3 increase in average carbon monoxide concentrations on the present day and previous day (lag 0-1), we observed significant increments in mortality of 1·12% (95% posterior interval [PI] 0·42-1·83) from cardiovascular disease, 1·75% (0·85-2·66) from coronary heart disease, and 0·88% (0·07-1·69) from stroke. These associations did not vary substantially by city, region, and demographic characteristics (age, sex, and level of education), and the associations for cardiovascular disease and coronary heart disease were robust to the adjustment of criteria co-pollutants. We did not find a threshold below which carbon monoxide exposure had no effect on cardiovascular disease mortality. This analysis is, to our knowledge, the largest study done in a developing country, and provides robust evidence of the association between short-term exposure to ambient carbon monoxide and increased cardiovascular disease mortality, especially coronary heart disease mortality. Public Welfare Research Program.

Spatiotemporal Variations in Chronic Obstructive Pulmonary Disease Mortality in China: Multilevel Evidence from 2006 to 2012

Mortality of Chronic Obstructive Pulmonary Disease (COPD) is on the decline in China. It is not known if this trend occurs across all areas or whether spatiotemporal variations manifest. We used data from the nationally representative China Mortality Surveillance System to calculate annual COPD mortality counts (2006–2012) stratified by 5-year age groups (aged > 20), gender and time for 161 counties and districts (Disease Surveillance Points, or DSP). These counts were linked to annually adjusted denominator populations. Multilevel negative binomial regression with random intercepts and slopes were used to investigate spatiotemporal variation in COPD mortality adjusting for age, gender and area-level risk factors. COPD mortality rate decreased markedly from 105.1 to 73.7 per 100,000 during 2006 to 2012 and varied over two-fold between DSPs across China. Mortality rates were higher in the west compared with the east (Rate ratio (RR) 2.15, 95% confidence intervals (CI) 1.73, 2.68) and in rural compared with the urban (RR 1.87, 95% CI 1.55, 2.25). Adjustment for age, gender, urban/rural, region, smoking prevalence, indoor air pollution, mean body mass index and socioeconomic circumstances accounted for 67% of the geographical variation. Urban/rural differences in COPD mortality narrowed over time, but the magnitude of the east-west inequality persisted without change. Immediate action via large-scale interventions to enhance the prevention and management of COPD are needed specifically within China's western region in order to tackle this crucial health inequality and leading preventable cause of death.

Cost-Effectiveness of Optimal Use of Acute Myocardial Infarction Treatments and Impact on Coronary Heart Disease Mortality in China

The cost-effectiveness of the optimal use of hospital-based acute myocardial infarction (AMI) treatments and their potential impact on coronary heart disease (CHD) mortality in China is not well known. The effectiveness and costs of optimal use of hospital-based AMI treatments were estimated by the CHD Policy Model-China, a Markov-style computer simulation model. Changes in simulated AMI, CHD mortality, quality-adjusted life years, and total healthcare costs were the outcomes. The incremental cost-effectiveness ratio was used to assess projected cost-effectiveness. Optimal use of 4 oral drugs (aspirin, β-blockers, statins, and angiotensin-converting enzyme inhibitors) in all eligible patients with AMI or unfractionated heparin in non-ST-segment-elevation myocardial infarction was a highly cost-effective strategy (incremental cost-effectiveness ratios approximately US $3100 or less). Optimal use of reperfusion therapies in eligible patients with ST-segment-elevation myocardial infarction was moderately cost effective (incremental cost-effectiveness ratio ≤$10,700). Optimal use of clopidogrel for all eligible patients with AMI or primary percutaneous coronary intervention among high-risk patients with non-ST-segment-elevation myocardial infarction in tertiary hospitals alone was less cost effective. Use of all the selected hospital-based AMI treatment strategies together would be cost-effective and reduce the total CHD mortality rate in China by ≈9.6%. Optimal use of most standard hospital-based AMI treatment strategies, especially combined strategies, would be cost effective in China. However, because so many AMI deaths occur outside of the hospital in China, the overall impact on preventing CHD deaths was projected to be modest.

National trend in congenital heart disease mortality in China during 2003 to 2010: A population-based study

Previous studies suggest that mortality from congenital heart diseases (CHDs) is declining in the United States. But we do not know what the CHD mortality trend is in China, especially the rural versus urban patterns. Our study aimed to determine recent changes in death caused by CHD in China and describe CHD mortality in rural and urban Chinese populations. The data source was the China Ministry of Health 2003 to 2010 annual reports. Mortality was defined as death caused by CHD. Mortality rates for each year were calculated per 10,000,000 person-years. Poisson regression and descriptive analyses were conducted for overall trend and subgroup analysis was conducted by sex, age, and urban versus rural residency to understand potential disparities in mortality. From 2003 to 2010, the overall mortality rate increased from 141 per 10,000,000 person-years in 2003 to 229 per 10,000,000 person-years in 2010, a 62.4% relative increase. This represents a region-sex adjusted annual increase of 9% (incidence rate ratio, 1.09; 95% confidence interval, 1.09-1.10). The increase in CHD mortality was not uniformly observed across age groups, urban versus rural residence, and sex. The relative increases were 65.3%, 212.2%, and 131.7% for ages 1 to 10 years, 21 to 64 years, and 65 years or older groups, respectively. Urban areas had a relative increase of 154.5% versus 5.3% for rural areas. Females who lived in an urban environment had a relative increase of 313.5%. Our observation showed an obvious increasing trend of CHD mortality in China. What is more, the increase in CHD mortality was not uniformly observed across subgroups. Such information is needed for strategy-making procedures.

Trend analysis on the mortality of cardiovascular diseases from 2004 to 2010 in China

To explore the trend and characteristics of cardiovascular disease mortality in China. Mortality data from the National disease surveillance system from 2004 to 2010 was used. Underreporting was adjusted and trends were analyzed on the rates of crude mortality, standardized mortality and causes of death fraction among cardiovascular diseases. The total mortality of cardiovascular diseases increased from 240.03 to 268.92 per one hundred thousand during 2004 to 2010, with an average annual increase of 5.50 per one hundred thousand, with the annual increase of 2.17% . Data from all causes of death, ischemic heart disease, hypertensive heart disease, cerebrovascular disease, and other heart disease showed an upward trend, with the annual rise of 5.05%, 2.08%, 1.02% and 2.66% respectively while rheumatic heart disease showed a downward trend, with the declining rate of 7.02% per annum. After eliminating the effect of aging, the trend remained the same but the slope was decreasing. The proportion of national cardiovascular mortality on total deaths increased annually by 37.46% to 40.73% from 2004 to 2010. The proportion of cerebrovascular disease remained unchanging but the proportion of ischemic heart disease showed a significant increase. The proportion of rheumatic heart disease declined while the proportion of other cardiovascular disease mortality showing a slight change. In recent years, the cardiovascular mortality had significantly increased, which was mainly due to the increase of ischemic heart disease mortality.

Coronary heart disease mortality in China: age, gender, and urban-rural gaps during epidemiological transition

To examine and describe coronary heart disease (CHD) mortality and its pattern of change (trend) by sex, age, and area of residence (urban versus rural) in Tianjin, China, within the context of epidemiological transition, and compare it with current trends in the Americas and Europe. A total of 104 393 cases of CHD death in Tianjin occurring between 1999 and 2008 were monitored. Death due to CHD was coded using International Classification of Diseases (ICD) standards (ninth and tenth revisions). Standardized CHD mortality rates and their trends were analyzed by age, sex, and urban versus rural residence. During the 10-year study period, the proportion of total deaths due to CHD in Tianjin increased significantly (from 16% to 24%) and age-standardized CHD mortality increased slightly (with no statistical differences), in contrast to CHD mortality trends in various countries in the Americas and Europe, which are declining. No difference was found in Tianjin's CHD mortality trend by sex. Overall CHD mortality was consistently higher among older age groups, males, and residents of urban areas. The proportion of CHD deaths occurring outside hospitals was 55.81%, with a declining trend over the study period. Rural areas had a higher proportion of outside-hospital CHD mortality than urban areas, but no difference was found across age groups. From 1999 to 2008, CHD mortality in Tianjin varied by sex, age, and urban versus rural area of residence. Future research to identify CHD risk factors and the populations most vulnerable to the disease is recommended to help strengthen CHD prevention. Strategies for CHD control similar to those used in various developed countries in the Americas and Europe should be developed to reduce the CHD burden in China.